Synthesis of Psoralidin derivatives and their anticancer activity: First synthesis of Lespeflorin I1

Tetrahedron

Volumn 72, Issue 23, 2016, Pages 3324-3334

  Pahari, Pallab ^a,c   Saikia, Ujwal Pratim ^a   Das, Trinath Prasad ^b   Damodaran, Chendil ^b   Rohr, Jürgen ^c  

^a Chemical Engineering Division   (India)

^b University of Louisville School of Medicine   (United States)

^c University of Kentucky   (United States)

Author keywords

Anticancer; Convergent synthesis; Prenylated coumestane; Psoralidin

Indexed keywords

1 BROMO 2,4 DIMETHOXY 5 METHYLBENZENE; 2 ALLYL 3 HYDROXY 6H BENZOFURO[3,2 C]CHROMEN 6 ONE; 2 ALLYL 3,8 DIHYDROXY 6H BENZOFURO[3,2 C]CHROMEN 6 ONE; 2 ALLYL 9 HYDROXY 6H BENZOFURO[3,2 C]CHROMEN 6 ONE; 2,4 DIMETHOXYBENZOIC ACID; 2,9 DIHYDROXY 3 (3 METHYLBUT 2 EN 1 YL) 6H BENZOFURO[3,2 C]CHROMEN 6 ONE; 3 ALLYL 2,9 DIHYDROXY 6H BENZOFURO[3,2 C]CHROMEN 6 ONE; 3 HYDROXY 2 (3 METHYLBUT 2 EN 1 YL) 6H BENZOFURO[3,2 C]CHROMEN 6 ONE; 3,8 DIHYDROXY 2 (3 METHYLBUT 2 EN 1 YL) 6H BENZOFURO[3,2 C]CHROMEN 6 ONE; 3,9 DIHYDROXY 2 METHYL 6H BENZOFURO[3,2 C]CHROMEN 6 ONE; 3,9 DIHYDROXY 6H BENZOFURO[3,2 C]CHROMEN 6 ONE; 4 ALLYL 2,5 DIMETHOXYBENZOIC ACID; 5 ALLYL 2 METHOXYBENZOIC ACID; 5 ALLYL 2,3,4 TRIMETHOXYBENZOIC ACID; 9 HYDROXY 2 (3 METHYLBUT 2 EN 1 YL) 6H BENZOFURO[3,2 C]CHROMEN 6 ONE; ANTINEOPLASTIC AGENT; LESPEFLORIN I1; METHYL 2 (2 METHOXYPHENYL)ACETATE; METHYL 2 (2,4,5 TRIMETHOXYPHENYL)ACETATE; METHYL 2,3 BIS(2,4 DIMETHOXYPHENYL) 3 OXOPROPANOATE; METHYL 2,3,4 TRIMETHOXYPHENYLACETATE; METHYL 2,5 DIMETHOXYPHENYLACETATE; METHYL 3 (2,4 DIMETHOXY 5 METHYLPHENYL) 2 (2,4 DIMETHOXYPHENYL) 3 OXOPROPANOATE; METHYL 3 (4 ALLYL 2,5 DIMETHOXYPHENYL) 2 (2,4 DIMETHOXYPHENYL) 3 OXOPROPANOATE; METHYL 3 (5 ALLYL 2 ,4 DIMETHOXYPHENYL) 2 (2 METHOXYPHENYL) 3 OXOPROPANOATE; METHYL 3 (5 ALLYL 2 METHOXYPHENYL) 2 (2,4 DIMETHOXYPHENYL) 3 OXOPROPANOATE; METHYL 3 (5 ALLYL 2,4 DIMETHOXYPHENYL) 2 (2,5 DIMETHOXYPHENYL) 3 OXOPROPANOATE; METHYL 3 (5 ALLYL 2,4 DIMETHOXYPHENYL) 3 OXO 2 (2,4,5 TRIMETHOXYPHENYL)PROPANOATE; PSORALIDIN DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CARBON NUCLEAR MAGNETIC RESONANCE; CASTRATION RESISTANT PROSTATE CANCER; CONTROLLED STUDY; DEMETHYLATION; DRUG OXIDATION; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HYDROGEN BOND; MALE; MELANOCYTE; METHYLATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROSTATE CANCER; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION;

EID: 84965050259     PISSN: 00404020     EISSN: 14645416     Source Type: Journal    
DOI: 10.1016/j.tet.2016.04.066     Document Type: Article

References (52)

1. H.N. Khastagir, P. Sengupta, and P.C. Duttagupta Tetrahedron 14 1961 275 283
2. B. Chopra, A.K. Dhingra, and K.L. Dhar Fitoterapia 90C 2013 44 56
3. J.M. Guo, X.C. Weng, H. Wu, Q.H. Li, and K.S. Bi Food Chem. 91 2005 287 292
4. L.T. Yi, Y.C. Li, Y. Pan, H.M. Li, Q. Xu, S.F. Mo, C.F. Qiao, F.X. Jiang, H.X. Xu, X.B. Lu, L.D. Kong, and H.F. Kung Prog. Neuropsychopharmacol. Biol. Psychiatry 32 2008 510 519
5. Y.C. Chen, Y.T. Cheung, L.D. Kong, T.B. Ng, C.F. Qiao, S.F. Mo, H.X. Xu, and H.F. Kung Life Sci. 82 2008 1117 1121
6. N.A. Khatune, M.E. Islam, M.E. Haque, P. Khondkar, and M.M. Rahman Fitoterapia 75 2004 228 230
7. K.Y. Oh, J.H. Lee, M.J. Curtis-Long, J.K. Cho, J.Y. Kim, W.S. Lee, and K.H. Park Food Chem. 121 2010 940 945
8. Y.C. Kim, H. Oh, B.S. Kim, T.H. Kang, E.K. Ko, Y.M. Han, B.Y. Kim, and J.S. Ahn Planta Med. 71 2005 87 89
9. K.D. Wook, S.K. Hye, C.-L.J. Marcus, O.K. Yeol, O. Jong-Won, C.H. Keun, L.K. Ho, and P.K. Hun J. Enzyme Inhib. Med. Chem. 29 2014 59 63
10. W.F. Chiou, M.J. Don, J.F. Liao, and B.L. Wei Eur. J. Pharmacol. 650 2011 102 109
11. H.J. Yang, H.S. Youn, K.M. Seong, Y.J. Yun, W. Kim, Y.H. Kim, J.Y.K. Lee, S. Cha, Y.-W. Jin, and B.H. Youn Biochem. Pharmacol. 82 2011 524 534
12. J.-P. Li, X.-J. Wang, Y. Zeng, Q. Lin, X.-M. Mo, S.-J. Liu, and J. Yang China J. Chin. Mater. Med. 38 2013 1816 1819
13. W. Mar, K.H. Je, and E.K. Seo Arch. Pharmacal Res. 24 2001 211 213
14. Y.M. Yang, J.W. Hyun, M.S. Sung, H.S. Chung, B.K. Kim, W.H. Paik, S.S. Kang, and J.G. Park Planta Med. 62 1996 353 354
15. W.D. Li, C.P. Yan, Y. Wu, Z.B. Weng, F.Z. Yin, G.M. Yang, B.C. Cai, and Z.P. Chen Phytomedicine 21 2014 400 405
16. X. Liu, J.-W. Nam, Y.S. Song, A.N.I. Viswanath, A.N. Pae, Y.-S. Kil, H.-D. Kim, J.H. Park, E.-K. Seo, and M. Chang Bioorg. Med. Chem. Lett. 24 2014 1403 1406
17. S. Liu, J. Wu, X. Zou, and Z. Liu Faming Zhuanli Shenqing 2013 CN 103251869 A 20130821
18. J. Bronikowska, E. Szliszka, D. Jaworska, Z.P. Czuba, and W. Krol Molecules 17 2012 6449 6464
19. E. Szliszka, Z.P. Czuba, L. Sedek, A. Paradysz, and W. Krol Pharmacol. Rep. 63 2011 139 148
20. R.S. Ranga, R. Girija, M. Nur-e-alam, S. Sathishkumar, M.A. Akbarsha, S. Thirugnanam, J. Rohr, M.M. Ahmed, and D. Chendil Cancer Chemother. Pharmacol. 54 2004 7 15
21. R. Kumar, S. Srinivasan, P. Pahari, J. Rohr, and C. Damodaran Mol. Cancer Ther. 9 2010 2488 2496
22. S. Srinivasan, R. Kumar, S. Koduru, A. Chandramouli, and C. Damodaran Apoptosis 15 2010 153 161
23. T.P. Das, S. Suman, and D. Chendil Mol. Carcinog. 53 2014 537 547
24. X. Chen, Y. Liu, J. Wu, H. Huang, Z. Du, K. Zhang, D. Zhou, K. Hung, S. Goodin, and X. Zheng Cancer Genomics Proteomics 13 2016 151 160
25. S. Karanika, T. Karantanos, S. Kurosaka, J. Wang, T. Hirayama, G. Yang, S. Park, A.A. Golstov, R. Tanimoto, L. Li, and T.C. Thompson Mol. Cancer 14 2015 122 134
26. M.D. Galsky, A. Dritselis, P. Kirkpatrick, and W.K. Oh Nat. Rev. Drug Discov. 9 2010 677 678
27. F. Vignani, V. Bertaglia, C. Buttigliero, M. Tucci, G.V. Scagliotti, and M. Di Maio Cancer Treat. Rev. 44 2016 61 73
28. C.A. James, A.L. Coelho, M. Gevaert, P. Forgione, and V. Snieckus J. Org. Chem. 74 2009 4094 4103
29. T. Yao, D. Yue, and R.C. Larock J. Org. Chem. 70 2005 9985 9989
30. N. Al-Maharik, and N.P. Botting Tetrahedron 60 2004 1637 1642
31. C.C. Li, Z.X. Xie, Y.D. Zhang, J.H. Chen, and Z. Yang J. Org. Chem. 68 2003 8500 8504
32. Y.R. Lee, J.Y. Suk, and B.S. Kim Org. Lett. 2 2000 1387 1389
33. S.A. Rodriguez, and M.T. Baumgartner Tetrahedron Lett. 51 2010 5322 5324
34. G.A. Kraus, and N. Zhang J. Org. Chem. 65 2000 5644 5646
35. L. Tang, Y. Pang, Q. Yan, L. Shi, J. Huang, Y. Du, and K. Zhao J. Org. Chem. 76 2011 2744 2752 and references therein
36. A. Fürstner, E.K. Heilmann, and P.W. Davies Angew. Chem., Int. Ed. 46 2007 4760 4763
37. Y.L. Jin, S. Kim, Y.S. Kim, S.A. Kim, and H.S. Kim Tetrahedron Lett. 49 2008 6835 6837
38. A.C. Jain, S.M. Jain, S.M. Gupta, and K.V. Singh Indian J. Chem. Sect. B 23 1984 1028 1029
39. P. Pahari, and J. Rohr J. Org. Chem. 74 2009 2750 2754
40. M. Mori-Hongo, H. Takimoto, T. Katagiri, M. Kimura, Y. Ikeda, and T. Miyase J. Nat. Prod. 72 2009 194 203
41. A.K. Barua, M. Chakrabarty, P.K. Datta, and S. Ray Phytochemistry 27 1988 3259 3261
42. Y.L. Lin, J.L. Huang, C.S. Wu, H.G. Liu, and D.Y. Yang Bioorg. Med. Chem. Lett. 12 2002 1709 1713
43. G. Buchi, and S.M. Weinreb J. Am. Chem. Soc. 93 1971 746 752
44. R.S. Varma, M. Varma, and A.K. Chatterjee J. Chem. Soc., Perkin Trans. 1 1993 999 1000
45. A. Einhorn, J. Cobliner, and H. Pfeiffer Ber. 37 1904 100 123
46. H. Hillemann Ber. 71 1938 34 41
47. S. Suman, T.P. Das, R. Reddy, A.M. Nyakeriga, J.E. Luevano, D. Konwar, P. Pahari, and C. Damodaran Br. J. Cancer 111 2014 309 317
48. K. Kobayashi, H. Shimizu, M. Itoh, and H. Suginome Bull. Chem. Soc. Jpn. 63 1990 2435 2437
49. H.M. Chawla, and K. Chakrabarty J. Chem. Soc., Perkin Trans. 1 1984 1511 1513
50. S.D. Higgins, and C.B. Thomas J. Chem. Soc., Perkin Trans. 1 1982 235 242
51. K. Maruyama, and T. Kozuka Bull. Chem. Soc. Jpn. 51 1978 3586 3589
52. A. Patra, and P.K. Mukhopadhyay J. Ind. Chem. Soc. 60 1983 265 268